maprotiline has been researched along with thyroxine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Goldberg, IJ; Lawton, K; Ridges, AP | 1 |
| Bishop, FM; Goldberg, IJ; Lawton, K; Ridges, AP | 1 |
1 review(s) available for maprotiline and thyroxine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for maprotiline and thyroxine
| Article | Year |
|---|---|
The effect of depression and its treatment on serum thyroxine.
Topics: Clomipramine; Depression; Dibenzazepines; Humans; Maprotiline; Thyroxine | 1977 |
Amine metabolism, thyroid function and response to clomipramine and maprotiline medication in depression.
Topics: Adolescent; Adult; Aged; Anthracenes; Clomipramine; Depression; Female; Humans; Hydroxyindoleacetic Acid; Male; Maprotiline; Middle Aged; Thyroxine | 1980 |